在不同全球人口中患有状细胞贫血的儿童中,氨酸尿素的药理动力学
Alexandra Power-Hays1, Kathryn E McElhinney2, Thomas N Williams3
1Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States.
Blood advances
|September 30, 2025
概括
用于状细胞贫血 (SCA) 的氨酸尿素剂量显示全球儿科群体的药理动力学差异很小. 这表明,单一的剂量模式可以优化全球SCA儿童的治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科 儿科 儿科
- 血液学 血液学 血液学
背景情况:
- 氧尿素是状细胞贫血 (SCA) 的关键治疗方法,通过修改疾病进展来改善结果.
- 由于药代动力学 (PK) 差异,基尿素剂量存在显著的患者间变异,影响治疗疗效.
- 了解区域性PK变异对于优化多样化儿科群体中基尿素治疗至关重要.
研究的目的:
- 为了比较全球不同地区SCA儿童的基尿素PK参数.
- 确定现有的PK模型是否适用于指导多种人群中基尿素剂量.
- 为了确定影响酸PK和剂量建议的因素.
主要方法:
- 来自五项国际临床试验 (美国,非洲,加勒比海) 的SCA儿童中氨酸尿素的比较PK分析.
- 使用HdxSimTM,一个经过验证的软件,来确定关键的PK参数.
- 进行统计比较 (ANOVA,回归分析) 以评估区域差异和影响变量.
主要成果:
- 水氧尿素PK参数在非洲,美国和加勒比海的SCA儿童中显示出极小的差异.
- 在非洲儿童中观察到的分布量略低,但吸收和清除是相似的.
- 达到最大耐受剂量 (MTD) 的PK推剂量在统计学上是不同的,但在不同地区的临床上是可比的.
结论:
- 患有SCA的儿童的基尿素PK因全球区域而异,差异很小,支持使用统一的PK人口模型.
- 基于PK的个性化基尿素剂量策略可以广泛应用,以优化全球SCA儿童的MTD成就.
- 这项研究为全球SCA管理提供了更广泛的有效基尿素疗法.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
193
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
193
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
254
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
246
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
01:29Drug Dosing: Infants and Children
255
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
255
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
237
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
237